DelveInsight’s, “Microbiome Competitive Landscape 2023” report provides comprehensive insights about 130+ Microbiome companies and 180+ drugs in Microbiome Competitive landscape. It covers the Microbiome therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from the Microbiome Competitive Landscape Report
- DelveInsight’s Microbiome report depicts a robust space with 130+ Microbiome companies working to develop 180+ pipeline therapies for Microbiome treatment.
- The leading Microbiome Companies working in the market include Ferring Pharmaceuticals, Miyarisan Pharmaceutical, Seres therapeutics, 4D Pharma, Caelus Health, MRM Health, Scioto Biosciences, Adiso Therapeutics, Servatus Biopharmaceuticals, Second Genome, Finch Research and Development LLC., MaaT Pharma, Qu Biologics, Da Volterra, Exeliom Biosciences, and others.
- Promising Microbiome Therapies in the various stages of development include Arabinogalactan, Maltodextrin, Omadacycline, Vancomycin Pill, Crisaborole 2% Top Oint, and others.
- December 2023: Viome Company– This is a longitudinal, observational study to understand vaginal microbiome changes both within a single day and across a menstrual cycle. The study will be composed of at least 10 women who have regular menstrual cycles and are 18 years of age or older. This study is direct to participants and will NOT utilize clinical sites.
- April 2023: ADM, a global leader in nutrition that powers many of the world’s top food, beverage, and health and wellness brands, and Brightseed, the bioactives company and a World Economic Forum Global Innovator, announced a global joint partnership to develop evidence-based functional synbiotic products that target microbiome optimization with an undisclosed investment. ADM is leveraging Brightseed’s artificial intelligence (A.I.) platform, Forager®, to decipher the molecular interactions between dietary plants and gut microbes, and their potential impact on human health.
- March 2023: Sequential Skin Inc. (“Sequential”), the skin microbiome company developing next-generation non-invasive skin testing and data-driven solutions for the skin microbiome, announced that it has entered into a collaboration agreement with Johnson & Johnson Consumer Inc. The collaboration will focus on developing new methods for non-invasive genomic-based skin testing, to help Sequential add to their growing database of skin samples.
Request a sample and discover the recent advances in Microbiome Drugs @ Microbiome Competitive Landscape Report
The Microbiome Report provides in-depth commercial assessment of Microbiome drugs that have been included, which comprises collaboration, agreement, licensing and acquisition – deals values trends. The sub-segmentation is described in the report which provide company-company collaboration (licensing/partnering), company academic collaboration and acquisition analysis in tabulated form.
Microbiome Overview
Microbiome refers to collection of microbes and their interaction with the human body. Microbiome plays an important role in human physiology and disease. The microbes and their interaction with the human body show the various aspects of human biology.
Find out more about Microbiome Analytical Perspective: In-depth Commercial Assessment @ Microbiome Collaboration Analysis by Companies
Microbiome Companies and Therapies
- Seres Therapeutics: SER-109
- 4D Pharma: Blautix
- Scioto Biosciences Inc.: SB-121
- Seres Therapeutics: SER-302
Microbiome Competitive Landscape
The Microbiome report comprises of comparative assessment of Companies (by therapy, development stage, and technology).
Microbiome Report Assessment
- Microbiome Company Analysis
- Microbiome Therapeutic Assessment
- Microbiome Pipeline Assessment
- Microbiome Inactive Drugs Assessment
- Microbiome Unmet Needs
Learn more about the emerging Microbiome Competitive Landscape @ Microbiome Market Drivers and Barriers, Unmet Needs
Scope of the Microbiome Competitive Landscape Report
- Coverage- Global
- Microbiome Companies- Ferring Pharmaceuticals, Miyarisan Pharmaceutical, Seres therapeutics, 4D Pharma, Caelus Health, MRM Health, Scioto Biosciences, Adiso Therapeutics, Servatus Biopharmaceuticals, Second Genome, Finch Research and Development LLC., MaaT Pharma, Qu Biologics, Da Volterra, Exeliom Biosciences, and others.
- Microbiome Therapies- Arabinogalactan, Maltodextrin, Omadacycline, Vancomycin Pill, Crisaborole 2% Top Oint, and others.
- Microbiome Therapeutics Assessment- Product Type, Stage and Product Type, Route of Administration, Stage and Route of Administration, Molecule Type, Stage and Molecule Type
Dive deep into rich insights for new drugs for Microbiome Product Developmental Activities, Visit @ Microbiome Research and Development Activities
Table of Content
- Introduction
- Executive Summary
- Microbiome: Overview
- Microbiome-Analytical Perspective: In-depth Commercial Assessment
- Competitive Landscape
- Therapeutic Assessment
- Microbiome: Company and Product Profiles (Marketed Therapies)
- Ferring pharmaceuticals
- RBX 2660
- Microbiome: Company and Product Profiles (Pipeline Therapies)
- Late Stage Products (Registered)
- Seres Therapeutics
- SER-109
- Drug profiles in the detailed report…..
- Mid Stage Products (Phase II)
- 4D Pharma
- Blautix
- Drug profiles in the detailed report…..
- Early Stage Products (Phase I)
- Seres Therapeutics
- SER-301
- Drug profiles in the detailed report…..
- Preclinical and Discovery Stage Products
- Company Name
- Product Name
- Drug profiles in the detailed report…..
- Inactive Products
- Microbiome Unmet needs
- Microbiome Market drivers and barriers
- Appendix
For further information on the Microbiome Report @ Microbiome Preclinical and Discovery Stage Products
About Us
DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: Send Email
Phone: 9650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/report-store/metastatic-melanoma-market